Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Psychemedics Corporation

Symbol: PMD     Sector: Healthcare     Industry: Medical Diagnostics & Research

Dividend Yield
7.62%
Current Price
$9.45
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 20:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
9,758,000
9,822,000
5,414,000
4,408,000
3,464,000
944,000
627,000
13,473,000
25,529,000
7,036,000
18,493,000
3,226,000
416,000
7,138,000
1,525,000
-839,000
368,000
 
420,000

Financials 2018

Update: 2019-06-10 20:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
9,873,000
9,936,000
5,203,000
4,733,000
3,205,000
1,528,000
881,000
13,870,000
24,974,000
6,227,000
18,747,000
4,069,000
416,000
7,974,000
1,628,000
-2,321,000
3,922,000
 
462,000

Q 3

2018-09-30
10,928,000
11,016,000
5,658,000
5,358,000
3,238,000
2,120,000
1,275,000
15,442,000
26,986,000
8,472,000
18,514,000
6,016,000
941,000
6,016,000
2,660,000
-1,431,000
407,000
 
372,000

Q 2

2018-06-30
10,676,000
10,787,000
5,615,000
5,172,000
3,116,000
2,056,000
1,177,000
14,381,000
26,425,000
8,168,000
18,257,000
7,721,000
957,000
7,721,000
2,899,000
558,000
2,194,000
 
358,000

Q 1

2018-03-31
10,821,000
10,935,000
5,580,000
5,355,000
3,449,000
1,906,000
1,251,000
15,543,000
27,729,000
8,558,000
19,171,000
8,284,000
957,000
8,284,000
3,138,000
125,000
1,406,000
 
359,000

Financials 2017

Update: 2019-06-10 20:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
10,076,000
9,759,000
4,983,000
4,776,000
2,830,000
1,946,000
2,350,000
13,865,000
26,508,000
7,888,000
18,620,000
8,165,000
957,000
8,165,000
3,377,000
2,813,000
2,029,000
 
352,000